胸部主動脈覆膜支架的開發平台 - 開發階段,市場區隔,地區和國家,法規途徑,主要企業(2023年版)
市場調查報告書
商品編碼
1271078

胸部主動脈覆膜支架的開發平台 - 開發階段,市場區隔,地區和國家,法規途徑,主要企業(2023年版)

Thoracic Aortic Stent Grafts Pipeline Report Including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update

出版日期: | 出版商: GlobalData | 英文 77 Pages | 訂單完成後即時交付

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

本報告提供胸部主動脈覆膜支架的開發中產品調查分析,包含各開發階段產品的比較分析,及進行中的臨床試驗相關之全面性資訊。

目錄

第1章 目錄

第2章 簡介

第3章 開發中的產品

  • 胸部主動脈覆膜支架 - 開發中產品:各開發階段
  • 胸部主動脈覆膜支架 - 開發中產品:各地區
  • 胸部主動脈覆膜支架 - 開發中產品:各法規途徑
  • 胸部主動脈覆膜支架 - 開發中產品:估計核准日
  • 胸部主動脈覆膜支架 - 進行中的臨床試驗

第4章 胸部主動脈覆膜支架 - 正在開發的開發中產品:各企業

  • 胸部主動脈覆膜支架企業 - 開發中產品:各開發階段
  • 胸部主動脈覆膜支架 - 開發中產品:各開發階段

第5章 胸部主動脈覆膜支架的企業和產品概要

  • APT Medical Inc:企業概要
    • APT Medical Inc:開發中產品和進行中的臨床試驗概要
  • Artivion Inc:企業概要
    • Artivion Inc:開發中產品和進行中的臨床試驗概要
  • 北京 Tianzhu Ruichang Medical Technology Co Ltd:企業概要
    • 北京 Tianzhu Ruichang Medical Technology Co Ltd:開發中產品和進行中的臨床試驗概要
  • EndoSpan Ltd:企業概要
    • EndoSpan Ltd:開發中產品和進行中的臨床試驗概要
  • Evasc Medical Systems Corp:企業概要
    • Evasc Medical Systems Corp:開發中產品和進行中的臨床試驗概要
  • Hangzhou Endonom Medtech Co Ltd:企業概要
    • Hangzhou Endonom Medtech Co Ltd:開發中產品和進行中的臨床試驗概要
  • JOTEC GmbH:企業概要
    • JOTEC GmbH:開發中產品和進行中的臨床試驗概要
  • Lombard Medical Technologies Inc.:企業概要
    • Lombard Medical Technologies Inc.:開發中產品和進行中的臨床試驗概要
  • Lundquist:企業概要
    • Lundquist:開發中產品和進行中的臨床試驗概要
  • Medtronic Plc:企業概要
    • Medtronic Plc:開發中產品和進行中的臨床試驗概要
  • Sree Chitra Tirunal Institute for Medical Sciences & Technology:企業概要
    • Sree Chitra Tirunal Institute for Medical Sciences & Technology:開發中產品和進行中的臨床試驗概要
  • St. Jude Medical LLC:企業概要
    • St. Jude Medical LLC:開發中產品和進行中的臨床試驗概要
  • Terumo Aortic:企業概要
    • Terumo Aortic:開發中產品和進行中的臨床試驗概要
  • TriVascular Inc:企業概要
    • TriVascular Inc:開發中產品和進行中的臨床試驗概要
  • Zylox-Tonbridge Medical Technology Co Ltd:企業概要
    • Zylox-Tonbridge Medical Technology Co Ltd:開發中產品和進行中的臨床試驗概要

第6章 胸部主動脈覆膜支架 - 最近的發展

第7章 附錄

簡介目錄
Product Code: GDME1520EPD

Abstract

GlobalData's Medical Devices sector report, "Thoracic Aortic Stent Grafts Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update" provides comprehensive information about the Thoracic Aortic Stent Grafts pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Thoracic aortic stent grafts are used to treat thoracic aortic aneurysms by reinforcing a part of the aorta using a minimally invasive procedure.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Thoracic Aortic Stent Grafts under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Thoracic Aortic Stent Grafts and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Thoracic Aortic Stent Grafts under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

  • 1.1 List of Tables
  • 1.2 List of Figures

2 Introduction

  • 2.1 Thoracic Aortic Stent Grafts Overview

3 Products under Development

  • 3.1 Thoracic Aortic Stent Grafts - Pipeline Products by Stage of Development
  • 3.2 Thoracic Aortic Stent Grafts - Pipeline Products by Territory
  • 3.3 Thoracic Aortic Stent Grafts - Pipeline Products by Regulatory Path
  • 3.4 Thoracic Aortic Stent Grafts - Pipeline Products by Estimated Approval Date
  • 3.5 Thoracic Aortic Stent Grafts - Ongoing Clinical Trials

4 Thoracic Aortic Stent Grafts - Pipeline Products under Development by Companies

  • 4.1 Thoracic Aortic Stent Grafts Companies - Pipeline Products by Stage of Development
  • 4.2 Thoracic Aortic Stent Grafts - Pipeline Products by Stage of Development

5 Thoracic Aortic Stent Grafts Companies and Product Overview

  • 5.1 APT Medical Inc Company Overview
    • 5.1.1 APT Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.2 Artivion Inc Company Overview
    • 5.2.1 Artivion Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.3 Beijing Tianzhu Ruichang Medical Technology Co Ltd Company Overview
    • 5.3.1 Beijing Tianzhu Ruichang Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.4 EndoSpan Ltd Company Overview
    • 5.4.1 EndoSpan Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.5 Evasc Medical Systems Corp Company Overview
    • 5.5.1 Evasc Medical Systems Corp Pipeline Products & Ongoing Clinical Trials Overview
  • 5.6 Hangzhou Endonom Medtech Co Ltd Company Overview
    • 5.6.1 Hangzhou Endonom Medtech Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.7 JOTEC GmbH Company Overview
    • 5.7.1 JOTEC GmbH Pipeline Products & Ongoing Clinical Trials Overview
  • 5.8 Lombard Medical Technologies Inc. Company Overview
    • 5.8.1 Lombard Medical Technologies Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.9 Lundquist Company Overview
    • 5.9.1 Lundquist Pipeline Products & Ongoing Clinical Trials Overview
  • 5.10 Medtronic Plc Company Overview
    • 5.10.1 Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.11 Sree Chitra Tirunal Institute for Medical Sciences & Technology Company Overview
    • 5.11.1 Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview
  • 5.12 St. Jude Medical LLC Company Overview
    • 5.12.1 St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.13 Terumo Aortic Company Overview
    • 5.13.1 Terumo Aortic Pipeline Products & Ongoing Clinical Trials Overview
  • 5.14 TriVascular Inc Company Overview
    • 5.14.1 TriVascular Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.15 Zylox-Tonbridge Medical Technology Co Ltd Company Overview
    • 5.15.1 Zylox-Tonbridge Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

6 Thoracic Aortic Stent Grafts- Recent Developments

  • 6.1 Apr 06, 2023: Merit Medical Systems to Announce First Quarter 2023 Results on April 26, 2023
  • 6.2 Mar 16, 2023: Medtronic joins in $25M funding round for home monitoring company
  • 6.3 Feb 23, 2023: LeMaitre Q4 2022 Financial Results
  • 6.4 Feb 03, 2023: Merit Medical Systems to Announce Fourth Quarter and Year End 2022 Results and Issue Fiscal Year 2023 Guidance on February 22, 2023
  • 6.5 Jan 30, 2023: Medtronic appoints Michael Blackwell as India vice-president
  • 6.6 Dec 07, 2022: Cook Medical welcomes Dr. John A. Kaufman as Chief Medical Officer
  • 6.7 Nov 23, 2022: Medtronic Reports Quarterly Earnings
  • 6.8 Nov 22, 2022: Medtronic reports second quarter fiscal 2023 financial results
  • 6.9 Nov 15, 2022: Medtronic Set to Announce Earnings on Tuesday
  • 6.10 Oct 17, 2022: LeMaitre Will Announce Third Quarter 2022 Earnings Results October 27, 2022
  • 6.11 Oct 13, 2022: Merit Medical Systems to Announce Third Quarter Results on October 26, 2022
  • 6.12 Sep 07, 2022: Medtronic to appear at September investor conferences
  • 6.13 Aug 31, 2022: LeMaitre to Present at the Morgan Stanley 20th Annual Global Healthcare Conference
  • 6.14 Aug 23, 2022: Medtronic reports first quarter fiscal 2023 financial results
  • 6.15 Aug 23, 2022: Medtronic Announces Quarterly Earnings Results
  • 6.16 Jul 28, 2022: LeMaitre Q2 2022 Financial Results
  • 6.17 Jul 27, 2022: Merit Medical Reports Results for Quarter Ended June 30, 2022
  • 6.18 Jul 18, 2022: LeMaitre Will Announce Second Quarter 2022 Earnings Results July 28, 2022
  • 6.19 Jul 14, 2022: Merit Medical Systems to Announce Second Quarter Results on July 27, 2022
  • 6.20 Jun 27, 2022: Medtronic Board appoints Lidia Fonseca as a new director
  • 6.21 May 27, 2022: Medtronic reports full year and fourth quarter fiscal year 2022 financial results
  • 6.22 May 26, 2022: Medtronic reports full year and fourth quarter fiscal year 2022 financial results announces 8% dividend increase
  • 6.23 Apr 28, 2022: LeMaitre Q1 2022 Financial Results
  • 6.24 Apr 27, 2022: Merit Medical Reports Results for Quarter Ended March 31, 2022
  • 6.25 Apr 21, 2022: Merit Medical Announces Chief Operating Officer Transition

7 Appendix

  • 7.1 Methodology
  • 7.2 About GlobalData
  • 7.3 Contact Us
  • 7.4 Disclaimer